CVC and GBL Launch 10.7 Billion Euro Bid for Recordati
CVC and GBL launched a 10.7 billion euro cash bid to take Italian drugmaker Recordati private. The deal includes backing from ADIA and the company chairman.
CVC Capital Partners PLC and Groupe Bruxelles Lambert NV launched a €10.7 billion cash bid on Friday to take Recordati private. The consortium is offering €51.29 per share, representing a 12.89% premium over Recordati's share price on March 25, the day before the Italian company announced CVC's interest. The deal reflects consolidation activity in the European pharmaceutical sector as private equity firms seek to scale fragmented healthcare assets.
### Unlocking Value Through Delisting CVC and GBL will partner as co-control investors to support Recordati's long-term development. A source with direct knowledge of the matter said the move aims to explore options across its primary care and rare disease lines.
